TrademarkDir
RAKUTEN MEDICAL
DEAD

Serial Number

90311854

Owner

RAKUTEN GROUP, INC.

Attorney

Anna Kurian Shaw

First Use Date

Apr 26, 2024

Filing Date

Nov 11, 2020

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

RAKUTEN MEDICAL Trademark

Serial Number: 90311854

RAKUTEN MEDICAL is a trademark filed by RAKUTEN GROUP, INC. on November 11, 2020. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). The application is currently no longer active.

Owner Contact Info

RAKUTEN GROUP, INC.

1-14-1 TAMAGAWA, SETAGAYA-KU
TOKYO 158-0094 , JP

Entity Type: 03

Rakuten, Inc.

Tokyo 158-0094 , JP

Entity Type: 03

Trademark Details

Filing Date

November 11, 2020

Registration Date

Not Registered

First Use Anywhere

April 26, 2024

First Use in Commerce

April 26, 2024

Published for Opposition

June 15, 2021

Goods & Services

Pharmaceutical preparations for the treatment and prevention of cancer; Pharmaceutical preparations for the treatment of cancer; Cancer treatment agent in the nature of pharmaceutical preparations; Pharmaceutical drugs for cancer treatment; Diagnostic agent used for cancer; Pharmaceutical preparations for the treatment and prevention of autoimmunological disorders and diseases, bacterial disorders and diseases, cardiovascular disorders and diseases, central and peripheral nervous system disorders and diseases, diabetic disorders and diseases, endocrine disorders and diseases, haematological disorders and diseases, hormonal disorders and diseases, gastrointestinal disorders and diseases, gout, immunological disorders and diseases, infectious disorders and diseases, inflammation and inflammatory disorders and diseases, musculoskeletal disorders and diseases, neurological disorders and diseases, oncological disorders and diseases, pain, respiratory disorders and diseases, urological and viral disorders and diseases; Medical preparations for the treatment and prevention of autoimmunological disorders and diseases, bacterial disorders and diseases, cardiovascular disorders and diseases, central and peripheral nervous system disorders and diseases, diabetic disorders and diseases, endocrine disorders and diseases, haematological disorders and diseases, hormonal disorders and diseases, gastrointestinal disorders and diseases, gout, immunological disorders and diseases, infectious disorders and diseases, inflammation and inflammatory disorders and diseases, musculoskeletal disorders and diseases, neurological disorders and diseases, oncological disorders and diseases, pain, respiratory disorders and diseases, urological and viral dis

Medical devices, apparatus and instruments for detecting and treating cancer, namely, lasers for medical use, lasers for medical purposes, lasers for medical use; Dental devices, apparatus and instruments for detecting and treating cancer namely, lasers for dental use, lasers for dental purposes, lasers for dental use

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Mar 11, 2026 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Mar 11, 2026 ABN2
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 25, 2025 GNRN
NON-FINAL ACTION E-MAILED
Nov 25, 2025 GNRT
SU - NON-FINAL ACTION - WRITTEN
Nov 25, 2025 CNRT
DIVISIONAL PROCESSING COMPLETE
Oct 27, 2025 DPCC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Oct 23, 2025 AITU
EXAMINER'S AMENDMENT ENTERED
Aug 28, 2025 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Aug 28, 2025 GNEN
EXAMINERS AMENDMENT E-MAILED
Aug 28, 2025 GNEA
SU-EXAMINER'S AMENDMENT WRITTEN
Aug 28, 2025 SNEA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 14, 2025 GNRN
NON-FINAL ACTION E-MAILED
May 14, 2025 GNRT
SU - NON-FINAL ACTION - WRITTEN
May 14, 2025 CNRT
ASSIGNED TO LIE
Dec 14, 2024 ALIE
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 13, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 13, 2024 CRFA
DIVISIONAL REQUEST RECEIVED
Nov 14, 2024 DRRR
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 14, 2024 TROA
TEAS REQUEST TO DIVIDE RECEIVED
Nov 14, 2024 ERTD
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 9, 2024 GNRN
NON-FINAL ACTION E-MAILED
Sep 9, 2024 GNRT
SU - NON-FINAL ACTION - WRITTEN
Sep 9, 2024 CNRT
STATEMENT OF USE PROCESSING COMPLETE
Aug 7, 2024 SUPC
USE AMENDMENT FILED
Aug 5, 2024 IUAF
TEAS STATEMENT OF USE RECEIVED
Aug 5, 2024 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 22, 2024 EXRA
SOU EXTENSION 5 GRANTED
Feb 21, 2024 EX5G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Feb 21, 2024 AITU
SOU EXTENSION 5 FILED
Feb 5, 2024 EXT5
SOU TEAS EXTENSION RECEIVED
Feb 5, 2024 EEXT
ASSIGNED TO EXAMINER
Oct 26, 2023 DOCK
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 10, 2023 EXRA
SOU EXTENSION 4 GRANTED
Aug 8, 2023 EX4G
SOU EXTENSION 4 FILED
Aug 8, 2023 EXT4
SOU TEAS EXTENSION RECEIVED
Aug 8, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 25, 2023 EXRA
SOU EXTENSION 3 GRANTED
Jan 23, 2023 EX3G
SOU EXTENSION 3 FILED
Jan 23, 2023 EXT3
SOU TEAS EXTENSION RECEIVED
Jan 23, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 9, 2022 EXRA
SOU EXTENSION 2 GRANTED
Aug 5, 2022 EX2G
SOU EXTENSION 2 FILED
Aug 5, 2022 EXT2
SOU TEAS EXTENSION RECEIVED
Aug 5, 2022 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 22, 2022 EXRA
SOU EXTENSION 1 GRANTED
Jan 20, 2022 EX1G
SOU EXTENSION 1 FILED
Jan 20, 2022 EXT1
SOU TEAS EXTENSION RECEIVED
Jan 20, 2022 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Aug 10, 2021 NOAM
POST PUBLICATION AMENDMENT - ENTERED
Jul 20, 2021 CHPB
ASSIGNED TO PETITION STAFF
Jul 19, 2021 APET
TEAS POST PUBLICATION AMENDMENT RECEIVED
Jun 24, 2021 EPPA
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 15, 2021 NPUB
PUBLISHED FOR OPPOSITION
Jun 15, 2021 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 26, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
May 10, 2021 CNSA
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
May 5, 2021 ASGN
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Apr 23, 2021 GNS3
LETTER OF SUSPENSION E-MAILED
Apr 23, 2021 GNSL
SUSPENSION LETTER WRITTEN
Apr 23, 2021 CNSL
EXAMINER'S AMENDMENT ENTERED
Apr 23, 2021 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Apr 23, 2021 GNEN
EXAMINERS AMENDMENT E-MAILED
Apr 23, 2021 GNEA
EXAMINERS AMENDMENT -WRITTEN
Apr 23, 2021 CNEA
ASSIGNED TO EXAMINER
Apr 14, 2021 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 11, 2021 NWOS
NEW APPLICATION ENTERED
Nov 14, 2020 NWAP

Related Trademarks

More from this Owner

RAKUTEN POINT

RAKUTEN POINT

RAKUTEN OPTIMISM

RAKUTEN OPTIMISM

RAKUTEN OPTIMISM

RAKUTEN OPTIMISM

RAKUTEN OPTIMISM

RAKUTEN OPTIMISM

RAKUTEN OPTIMISM

RAKUTEN OPTIMISM

CATEGORY2VEC

CATEGORY2VEC